Eduardo Vega, MD
Assistant Professor, Surgery
Biography
Dr. Vega, is a Hepato-Bilio-Pancreatic surgeon in the Department of Surgery at Saint Elizabeth Medical Center and Assistant Professor of Surgery BUSM. After completing residency in general surgery at Hospital Sotero del Rio, Santiago, Chile, Dr Vega served as Postdoctoral Fellow in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center from 2017 to 2019. Later, Dr Vega moved to Boston, Massachusetts to complete a fellowship in Minimally Invasive Hepato-Pancreato-Biliary (HPB) Surgery at Saint Elizabeth’s Medical Center of Tufts University. This experience lead to multiple publications that found innovative prognostic solutions for gallbladder cancer and pancreatic cancer which are being applied to clinical practice at MD Anderson and in Chile today.
Dr. Vega’s current research focuses on novel techniques/technologies to treat complex liver and pancreas cancer. In this context, he designed multiple innovative techniques for HPB disease that use 3D reconstruction software. This work has produced multiple publications in Annals Surgical Oncology and other peer-review journals. This reciprocal relationship between clinical surgery and research is a primary focus for Dr. Vega’s with an ultimate goal of applying innovative solutions to healthcare needs, especially in geographic areas with limited health resources.
Dr. Vega is currently a member of several national and international organizations including The Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons and a combined member of the International Hepato-Pancreato-Biliary Association and the Americas Hepato-Pancreato-Biliary Association. In the future, Dr. Vega hopes to remain active as both an academic clinical surgeon and a translational researcher.
Publications
- Published on 9/6/2023
Vega EA, Vauthey JN. Reply to: "Comment on: Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study," by Shi, Li-jun et al. Ann Surg Oncol. 2023 Nov; 30(12):7398-7399. PMID: 37672145.
Read at: PubMed - Published on 8/29/2023
Vega EA, Salehi O, Panettieri E, Salirrosas O, Brauner E, Mellado S, Dvir K, Perepletchikov A, Kozyreva O, Conrad C. Subsegmental approaches to S7: anatomic laparoscopic transdiaphragmatic and nonanatomic robotic transthoracic. Surg Endosc. 2023 Oct; 37(10):8154-8155. PMID: 37644157.
Read at: PubMed - Published on 8/7/2023
Mellado S, Chirban AM, Rivera B, Panettieri E, Vega EA. ASO Author Reflections: Precision in Gallbladder Cancer Care: Present Challenges and Future Directions. Ann Surg Oncol. 2023 Oct; 30(11):6601-6602. PMID: 37548834.
Read at: PubMed - Published on 8/1/2023
Vega EA, Mellado S, Newhook TE, Vauthey JN. ASO Visual Abstract: Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multi-center Study. Ann Surg Oncol. 2023 Aug; 30(8):4914-4915. PMID: 37179275.
Read at: PubMed - Published on 7/22/2023
Vega EA, Mellado S, Chirban AM, Vinuela E. ASO Visual Abstract: Analysis of the Extent of Liver Oncologic Extended Resection for Incidental Gallbladder Cancer: How Much is too Much? Ann Surg Oncol. 2023 Jul 22. PMID: 37481489.
Read at: PubMed - Published on 7/17/2023
Vega EA, Mellado S, Chirban AM, Panettieri E, Sanhueza M, Mege R, Diaz C, Brañes A, Briceño E, Viñuela E. Analysis of the Extent of Liver Oncological Extended Resection for Incidental Gallbladder Cancer: How Much Is Too Much? Ann Surg Oncol. 2023 Oct; 30(11):6594-6600. PMID: 37460736.
Read at: PubMed - Published on 7/3/2023
Vega EA, Agudile E, Salirrosas O, Chirban AM, Brauner E, Crocker A, Freeman R, Sorescu GP, Odisio BC, Conrad C. Clinical outcomes and cost of open, laparoscopic, and percutaneous ablation for hepatocellular carcinoma. J Surg Oncol. 2023 Oct; 128(5):812-822. PMID: 37395114.
Read at: PubMed - Published on 6/10/2023
Chirban AM, Vega EA, Kutlu OC, Mellado S, Kozyreva O, Zauls AJ, Panettieri E, Salirrosas O, Freeman R, Conrad C. R1 pancreatic cancer patients benefit from chemoradiation when initiation of adjuvant therapy is delayed. Surg Oncol. 2023 Aug; 49:101961. PMID: 37321066.
Read at: PubMed - Published on 5/18/2023
Vega EA, Mellado S, Panettieri E, Newhook T, Vauthey JN. ASO Author Reflections: Harnessing the Power of Data- The Impact of Benchmarking in Healthcare. Ann Surg Oncol. 2023 Aug; 30(8):4912-4913. PMID: 37202572.
Read at: PubMed - Published on 5/6/2023
Vega EA, Newhook TE, Mellado S, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, Rojas J, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OA, Munoz C, Denbo JW, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Torzilli G, Giuliante F, Anaya DA, Guglielmi A, Vinuela E, Vauthey JN. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study. Ann Surg Oncol. 2023 Aug; 30(8):4904-4911. PMID: 37149547.
Read at: PubMed
View 64 more publications: View full profile at BUMC